Market Place
Sourcing Support
All News #Library
Biotech
Amneal Pharma to buy Kashiv BioSciences in $1.1 billion deal
22 Apr 2026 //
REUTERS
Amneal Introduces New Brand To Enhance Medicine Accessibility
14 Jan 2026 //
EXPRESSPHARMA
KeifeRx, Amneal Pharma Partner on KFRX06 for Parkinson`s
09 Jan 2026 //
BUSINESSWIRE
Zambon Announce First patient dosed in Ph 3b ADIP study of IPX203
22 Dec 2025 //
PRESS RELEASE
Amneal Reports Positive Interim Phase 4 ELEVATE-PD Results
05 Dec 2025 //
GLOBENEWSWIRE
Amneal Submits Biosimilar BLA For Xolair (omalizumab)
26 Sep 2025 //
GLOBENEWSWIRE
Amneal, Kashiv Report Positive Data for Xolair Biosimilar
25 Jun 2025 //
GLOBENEWSWIRE
FDA Accepts Amneal’s BLA for Two Denosumab Biosimilars
03 Mar 2025 //
BUSINESSWIRE
Amneal Expands In India With Two New Manufacturing Facilities
08 Oct 2024 //
EXPRESSPHARMA
Amneal Adds Omalizumab Biosimilar To Portfolio, Now Eight Products
01 Jul 2024 //
BUSINESSWIRE
Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
27 Feb 2024 //
PRESS RELEASE
Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline
12 Oct 2023 //
BUSINESSWIRE
Amneal Launches Third Biosimilar with FYLNETRA™ (pegfilgrastim-pbbk)
16 May 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.